October 20, 2025 a 08:00 am

HSIC: Fundamental Ratio Analysis - Henry Schein, Inc.

Henry Schein, Inc. Stock

Henry Schein, Inc. operates in a robust sector, providing essential healthcare products and services worldwide. Despite recent market variability, the company's strategic focus on healthcare distribution and technology-enabled services positions it well for future growth. The stock shows a stable performance with room for improvement in certain financial metrics.

Fundamental Rating

Henry Schein's current fundamental rating stands at B+, indicating a stable financial health with balanced metrics across evaluation categories.

Category Score Visualization
Discounted Cash Flow 4
Return on Equity 3
Return on Assets 5
Debt to Equity 1
Price to Earnings 2
Price to Book 3

Historical Rating

The historical data shows consistent performance metrics over the recent period, reflecting stable operational efficiency.

Date Overall DCF ROE ROA Debt/Equity P/E P/B
2025-10-17 3 4 3 5 1 2 3
Prior 0 4 3 5 1 2 3

Analyst Price Targets

Analysts offer a mixed outlook with a median price target slightly above the current trading price, indicating modest potential for appreciation.

High Low Median Consensus
$86 $75 $83 $81.33
Henry Schein Stock Chart

Analyst Sentiment

Current analyst consensus is a 'Hold', with a notable number of analysts issuing buy recommendations, reflecting a balanced risk-reward outlook.

Recommendation Count Visualization
Strong Buy 0
Buy 13
Hold 14
Sell 3
Strong Sell 0

Conclusion

Henry Schein, Inc. maintains a strong foothold in the healthcare distribution market, with its diversified product lines aiding in stable revenue streams. Financial indicators suggest fundamental robustness, albeit with some leverage concerns. Analyst ratings propose a "Hold", signaling room for strategic growth or caution. The stock's potential for moderate appreciation is aligned with the current market scenario, yet external market factors could influence future performance significantly.